PL379631A1 - Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli - Google Patents

Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli

Info

Publication number: PL379631A1
Authority: PL; Poland
Prior art keywords: perindopril; synthesis; pharmaceutically acceptable; acceptable salts; novel method
Prior art date: 2003-07-31

Application number

PL379631A

Other languages

English (en)

Other versions

PL211892B1 (pl

Inventor

Claude Fugier

Thierry Dubuffet

Pascal Langlois

Original Assignee

Les Laboratoires Servier

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-31

Filing date

2004-07-29

Publication date

2006-10-30

2004-07-29 Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier

2006-10-30 Publication of PL379631A1 publication Critical patent/PL379631A1/pl

2012-07-31 Publication of PL211892B1 publication Critical patent/PL211892B1/pl

Links

230000015572 biosynthetic process Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
229960002582 perindopril Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL379631A 2003-07-31 2004-07-29 Sposób otrzymywania perindoprilu i jego farmaceutycznie dopuszczalnych soli oraz związek przejściowy PL211892B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03291931A EP1367063B1 (fr)	2003-07-31	2003-07-31	Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number	Publication Date
PL379631A1 true PL379631A1 (pl)	2006-10-30
PL211892B1 PL211892B1 (pl)	2012-07-31

Family

ID=29414890

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL379631A PL211892B1 (pl)	2003-07-31	2004-07-29	Sposób otrzymywania perindoprilu i jego farmaceutycznie dopuszczalnych soli oraz związek przejściowy

Country Status (27)

Country	Link
US (1)	US7358372B2 (pl)
EP (1)	EP1367063B1 (pl)
JP (1)	JP4263743B2 (pl)
KR (1)	KR100798560B1 (pl)
CN (1)	CN100404548C (pl)
AR (1)	AR045151A1 (pl)
AT (1)	ATE337332T1 (pl)
AU (1)	AU2004261439B2 (pl)
BR (1)	BRPI0413169A (pl)
CA (1)	CA2533005C (pl)
CY (1)	CY1105791T1 (pl)
DE (1)	DE60307721T2 (pl)
DK (1)	DK1367063T3 (pl)
EA (1)	EA008685B1 (pl)
ES (1)	ES2271498T3 (pl)
GE (1)	GEP20094740B (pl)
MA (1)	MA27911A1 (pl)
MX (1)	MXPA06001243A (pl)
MY (1)	MY139443A (pl)
NO (1)	NO333957B1 (pl)
NZ (1)	NZ544879A (pl)
PL (1)	PL211892B1 (pl)
PT (1)	PT1367063E (pl)
SI (1)	SI1367063T1 (pl)
UA (1)	UA80905C2 (pl)
WO (1)	WO2005012333A2 (pl)
ZA (1)	ZA200600479B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI21800A (sl) *	2004-05-14	2005-12-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	Nov postopek sinteze perindoprila
WO2016178591A2 (en)	2015-05-05	2016-11-10	Gene Predit, Sa	Genetic markers and treatment of male obesity
PH12018502155B1 (en)	2016-04-20	2024-03-27	Servier Lab	Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES8604144A1 (es)	1984-11-21	1986-01-16	Farmhispania	Procedimiento para la obtencion del acido (2s, 3as, 7as)-1-((s)-1-etoxicarbonil-3-fenilpropil) alanil) exahidro-2-indolincarboxilico
FR2807431B1 (fr) *	2000-04-06	2002-07-19	Adir	Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) *	2001-07-24	2004-12-10	Servier Lab	Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril

2003
- 2003-07-31 DE DE60307721T patent/DE60307721T2/de not_active Expired - Lifetime
- 2003-07-31 SI SI200330430T patent/SI1367063T1/sl unknown
- 2003-07-31 ES ES03291931T patent/ES2271498T3/es not_active Expired - Lifetime
- 2003-07-31 PT PT03291931T patent/PT1367063E/pt unknown
- 2003-07-31 DK DK03291931T patent/DK1367063T3/da active
- 2003-07-31 EP EP03291931A patent/EP1367063B1/fr not_active Expired - Lifetime
- 2003-07-31 AT AT03291931T patent/ATE337332T1/de active
2004
- 2004-07-29 NZ NZ544879A patent/NZ544879A/en not_active IP Right Cessation
- 2004-07-29 MY MYPI20043053A patent/MY139443A/en unknown
- 2004-07-29 AU AU2004261439A patent/AU2004261439B2/en not_active Ceased
- 2004-07-29 AR ARP040102693A patent/AR045151A1/es not_active Application Discontinuation
- 2004-07-29 US US10/566,562 patent/US7358372B2/en not_active Expired - Fee Related
- 2004-07-29 EA EA200600250A patent/EA008685B1/ru not_active IP Right Cessation
- 2004-07-29 KR KR1020067001920A patent/KR100798560B1/ko not_active Expired - Fee Related
- 2004-07-29 BR BRPI0413169-0A patent/BRPI0413169A/pt active Search and Examination
- 2004-07-29 MX MXPA06001243A patent/MXPA06001243A/es active IP Right Grant
- 2004-07-29 WO PCT/FR2004/002035 patent/WO2005012333A2/fr not_active Ceased
- 2004-07-29 GE GEAP20049261A patent/GEP20094740B/en unknown
- 2004-07-29 CN CNB2004800212090A patent/CN100404548C/zh not_active Expired - Fee Related
- 2004-07-29 PL PL379631A patent/PL211892B1/pl unknown
- 2004-07-29 ZA ZA200600479A patent/ZA200600479B/en unknown
- 2004-07-29 CA CA2533005A patent/CA2533005C/fr not_active Expired - Fee Related
- 2004-07-29 UA UAA200602130A patent/UA80905C2/xx unknown
- 2004-07-29 JP JP2006521621A patent/JP4263743B2/ja not_active Expired - Fee Related
2006
- 2006-01-17 MA MA28731A patent/MA27911A1/fr unknown
- 2006-02-24 NO NO20060922A patent/NO333957B1/no not_active IP Right Cessation
- 2006-11-16 CY CY20061101673T patent/CY1105791T1/el unknown

Also Published As

Publication number	Publication date
DE60307721T2 (de)	2007-10-18
AU2004261439B2 (en)	2008-03-13
US7358372B2 (en)	2008-04-15
MXPA06001243A (es)	2006-04-11
ES2271498T3 (es)	2007-04-16
NO20060922L (no)	2006-02-24
KR100798560B1 (ko)	2008-01-28
MA27911A1 (fr)	2006-05-02
CY1105791T1 (el)	2011-02-02
EA008685B1 (ru)	2007-06-29
DE60307721D1 (de)	2006-10-05
US20060183920A1 (en)	2006-08-17
GEP20094740B (en)	2009-07-27
DK1367063T3 (da)	2006-12-27
ATE337332T1 (de)	2006-09-15
EP1367063B1 (fr)	2006-08-23
PL211892B1 (pl)	2012-07-31
BRPI0413169A (pt)	2006-10-03
NZ544879A (en)	2009-03-31
CN1826352A (zh)	2006-08-30
AU2004261439A1 (en)	2005-02-10
PT1367063E (pt)	2006-12-29
EA200600250A1 (ru)	2006-06-30
NO333957B1 (no)	2013-10-28
JP2007526896A (ja)	2007-09-20
HK1096406A1 (en)	2007-06-01
SI1367063T1 (sl)	2006-10-31
MY139443A (en)	2009-10-30
CN100404548C (zh)	2008-07-23
EP1367063A1 (fr)	2003-12-03
WO2005012333A2 (fr)	2005-02-10
AR045151A1 (es)	2005-10-19
JP4263743B2 (ja)	2009-05-13
WO2005012333A3 (fr)	2005-03-24
CA2533005C (fr)	2010-04-06
UA80905C2 (en)	2007-11-12
KR20060032209A (ko)	2006-04-14
CA2533005A1 (fr)	2005-02-10
ZA200600479B (en)	2007-05-30

Publication	Publication Date	Title
AP2002002630A0 (en)	2002-09-30	Method for synthesis of perindopril and its pharmaceutically acceptable salts
AU2001248470A1 (en)	2001-11-01	Method for synthesis of perindopril and its pharmaceutically acceptable salts
ZA200510324B (en)	2007-03-28	Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
SI1420028T1 (sl)	2007-06-30	Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1367061T1 (sl)	2006-04-30	Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
EG24152A (en)	2008-08-19	Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
SI1380590T1 (sl)	2006-12-31	Postopek za sintezo perindoprila in njenih farmacevtsko sprejemljivih soli
SI1371659T1 (sl)	2006-02-28	Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1380591T1 (sl)	2006-02-28	Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1420029T1 (sl)	2008-08-31	Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1403275T1 (sl)	2006-02-28	Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
PL379625A1 (pl)	2006-10-30	Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
PL379631A1 (pl)	2006-10-30	Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
IL165802A0 (en)	2006-01-15	Process for the preparation of phenylalanine enamide derivatives
SI1422236T1 (sl)	2007-06-30	Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
PL1753720T3 (pl)	2014-09-30	Proces wytwarzania peryndoprylu i jego soli
AU2003210296A8 (en)	2003-09-04	Process for the preparation of 4-hetero-substituted phenylalanine derivatives
SI1268424T1 (sl)	2007-12-31	Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli